Tech Company Inital Public Offerings
Kala Pharmaceuticals IPO
Headquartered in Watertown, Kala Pharmaceuticals went public.
Transaction Overview
Company Name
Announced On
7/20/2017
Transaction Type
IPO
Amount
$90,000,000
Proceeds Purpose
We currently estimate that we will use the net proceeds from this offering as follows: approximately $25.0 million to fund clinical development of our KPI-121 product candidates, including preparation of NDA submissions for KPI-121 1.0% for the treatment of post-operative inflammation and pain following ocular surgery and for KPI-121 0.25% for the temporary relief of the signs and symptoms of dry eye disease; approximately $30.0 million to prepare for commercialization of KPI-121 1.0% and KPI-121 0.25%; approximately $20.0 million to support the manufacture of a commercial supply of KPI-121 product candidates; approximately $0.5 million to fund early stage pipeline development programs; and the remainder for working capital and other general corporate purposes, including scheduled payments on existing indebtedness and funding the costs of operating as a public company.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
490 Arsenal Way 120
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Website
Email Address
Overview
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) is a biotechnology company founded upon a proprietary drug delivery technology. By utilizing this unique technology, Kala aims to address unmet therapeutic needs of various diseases and conditions in a fundamentally novel way.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Iwicki
Chief Medical Officer
Kim Brazzell
Chief Operating Officer
Todd Bazemore
Chief Scientific Officer
Hongming Chen
VP - Finance
Mary Reumuth
VP - General Counsel
Eric Trachtenberg
VP - Manufacturing
Vincent Kosewski
Browse more venture capital transactions:
Prev: 7/20/2017: Vets First Choice venture capital transaction
Next: 7/20/2017: Carbice venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs